Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Beam Therapeutics (BEAM) Shares Outstanding (Diluted Average) (2019 - 2025)

Historic Shares Outstanding (Diluted Average) for Beam Therapeutics (BEAM) over the last 7 years, with Q3 2025 value amounting to $102.6 million.

  • Beam Therapeutics' Shares Outstanding (Diluted Average) rose 2446.39% to $102.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $102.6 million, marking a year-over-year increase of 2446.39%. This contributed to the annual value of $82.3 million for FY2024, which is 668.97% up from last year.
  • According to the latest figures from Q3 2025, Beam Therapeutics' Shares Outstanding (Diluted Average) is $102.6 million, which was up 2446.39% from $102.0 million recorded in Q2 2025.
  • Beam Therapeutics' Shares Outstanding (Diluted Average)'s 5-year high stood at $102.6 million during Q3 2025, with a 5-year trough of $60.2 million in Q1 2021.
  • Its 5-year average for Shares Outstanding (Diluted Average) is $76.8 million, with a median of $76.3 million in 2023.
  • Per our database at Business Quant, Beam Therapeutics' Shares Outstanding (Diluted Average) skyrocketed by 3743.47% in 2021 and then skyrocketed by 428.4% in 2024.
  • Quarter analysis of 5 years shows Beam Therapeutics' Shares Outstanding (Diluted Average) stood at $64.2 million in 2021, then increased by 9.01% to $70.0 million in 2022, then grew by 10.19% to $77.2 million in 2023, then grew by 6.69% to $82.3 million in 2024, then increased by 24.61% to $102.6 million in 2025.
  • Its Shares Outstanding (Diluted Average) was $102.6 million in Q3 2025, compared to $102.0 million in Q2 2025 and $88.0 million in Q1 2025.